Solara Active Pharma Sciences is an API manufacturer based in India. It holds 91 active US drug master files and 32 valid CEPs. Its GMP standing is certified by CDSCO (India), US FDA and EMA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 6 February 2026 as VAI. Customs aggregates show $85.7M of exports covering 1,240 molecules to 62 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Chennai, India | Not on file |
| Mysuru, India | 3011856449 |
| Anakapalli District, India | 3016965485 |
| New Mangalore, India | 3008252997 |
| Periyakalapet, India | 3002808058 |
| Pondicherry, India | Not on file |
6 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Ibuprofen | EDQM, SFDA (Saudi Arabia), US FDA | 9 |
| Mefenamic Acid | EDQM, US FDA | 4 |
| Colchicine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Dextromethorphan | EDQM, US FDA | 3 |
| Hydralazine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Levetiracetam | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Mycophenolic Acid | EDQM, US FDA | 3 |
| Succinylcholine | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Aprepitant | EDQM, US FDA | 2 |
| Bumetanide | EDQM, US FDA | 2 |
| Buspirone | EDQM, US FDA | 2 |
| Celecoxib | EDQM, US FDA | 2 |
| Dipyridamole | EDQM, US FDA | 2 |
| Disulfiram | EDQM, US FDA | 2 |
| Etomidate | EDQM, US FDA | 2 |
| Flecainide | EDQM, US FDA | 2 |
| Gabapentin | EDQM, US FDA | 2 |
| Mesalazine | EDQM, US FDA | 2 |
| Mesna | EDQM, US FDA | 2 |
| Mirabegron | EDQM, US FDA | 2 |
| Mycophenolate Mofetil | EDQM, SFDA (Saudi Arabia) | 2 |
| Naproxen | US FDA | 2 |
| Nizatidine | EDQM, US FDA | 2 |
| Olanzapine | EDQM, US FDA | 2 |
| Oseltamivir | EDQM, US FDA | 2 |
| Praziquantel | EDQM, US FDA | 2 |
| Sevelamer | US FDA | 2 |
| Venlafaxine | EDQM, US FDA | 2 |
| Acitretin | US FDA | 1 |
| Acyclovir | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| CDSCO (India) | 2 | 5 |
| US FDA | None | 5 |
| EMA | None | 3 |
| MFDS (Korea) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $13.8M | 40 |
| 2025 | Not reported | $85.7M | 62 |
| 2024 | Not reported | $95.4M | 63 |
| 2023 | Not reported | $95.8M | 63 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Solara Active Pharma Sciences comes back tiered against every other supplier able to file there.
Start for free